Corporate Overview & Mission
Cryo-Cell’s mission is to provide our clients with the premier stem cell cryopreservation service and to support research and development initiatives for regenerative medicine.
Pride in our people, our practices and our potential to save lives.
Founded in 1989, Cryo-Cell was the world's first private cord blood bank to separate and store stem cells in 1992. Today, the company has over 240,000 clients worldwide from 87 countries. Since inception, 100% of our clients’ specimens have been successfully viable upon thaw. Our services include umbilical cord blood, cord tissue and menstrual stem cell banking.
Some cord blood banks are simply marketing outlets that do not perform their own processing or storage. Cryo-Cell operates its own state-of-the-art processing, testing and cryopreservation operation. We are in complete control of every step, ensuring the highest quality available today.
Saneron CCEL Therapeutics, Inc.
Cryo-Cell holds an equity position in Saneron CCEL Therapeutics (Saneron), a University of South Florida spin-out biotechnology company. Saneron is committed to advancing research using readily available, non-controversial cord blood stem cells. Saneron’s research focus is to actively seek new cellular therapy discoveries for treatment of and intervention in devastating, life-threatening illness and conditions such as heart attack, Alzheimer’s disease, stroke, and spinal cord injury. For more information, visit Saneron’s Web site: www.saneron-ccel.com